Where's the bleed? A response to Piccini et al.'s: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
EUROPEAN HEART JOURNAL（2019）
摘要
This commentary refers to 'Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial', by J.P. Piccini et al., 2019;40:1568.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要